Traws Pharma OverviewTraws Pharma EBIT
EBIT (Earnings Before Interest and Taxes) analysis for TRAW.
Quarterly EBIT
-$2.50M
As of May 31, 2026
Annual EBIT (TTM)
-$4.06B
↓ 16213.19% YoY
Trailing 12 months ending May 31, 2026
Traws Pharma OverviewEBIT (Earnings Before Interest and Taxes) analysis for TRAW.
As of May 31, 2026
Trailing 12 months ending May 31, 2026